Spectrum of mutations in newly diagnosed acute myeloid leukemias in Novosibirsk
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Introduction. Differences in the frequency and spectrum of mutations in acute myeloid leukemia (AML) may be related to regional environmental factors (ionizing radiation or chemical mutagens) and the genetic predisposition of the population, while data on the Russian population are limited and presented in isolated publications with a “narrow” geography and a small sample size. Aim. Comprehensive analysis of mutations in the hot spots of the DNMT3A, NPM1, FLT3, IDH1 and IDH2 genes in AML patients living in Novosibirsk. Materials and methods. Genomic DNA isolated from the bone marrow of 128 patients with newly diagnosed AML was studied. p.W288Cfs*12 mutations of the NPM1 and FLT3-ITD genes were screened by polymerase chain reaction (PCR) with flanking primers; screening for the p.R882 mutation of the DNMT3A gene, p.D835 of the FLT3 gene, p.R132 of the IDH1 gene, and p.R140 of the IDH2 gene was performed by PCR with analysis of restriction fragment length polymorphism (PCR-RFLP). Exact verification of the mutation was carried out by direct capillary sequencing according Sanger. Results. In the study group, in 42,2% of cases revealed some clinically, prognostically, and therapeutically significant findings. In total, 22,6% of the patients in the study group had mutations in the hot spots of the genes of epigenetic genome regulation: IDH1, IDH2 and DNMT3A. At the same time, mutations in two or more analyzed genes occurred in half of the cases (51,9%) with findings. In the study group, the mutation rate was 9,3% for p.R882 of the DNMT3A gene, 14,8% for p.W288Cfs*12 in the NPM1 gene, 18,0% for FLT3-TKD and FLT3-ITD, 5,5% for p.R132 of the IDH1 gene, and 10,2% for p.R140 in the IDH2 gene, which corresponded to data from the cBioPortal for Cancer Genomics (p > 0,05). In an isolated variant, the p.W288Cfs*12 mutation of the NPM1 gene was detected in 7 out of 19 (36,8%) patients with this mutation. Conclusion. For the first time, a comprehensive picture of the spectrum of mutations in the analyzed hot spots of the DNMT3A, IDH1, IDH2, FLT3, and NPM1 genes was obtained in de novo AML in patients living in the Siberian region. In more than a third of cases, the analysis of the hot spots of the studied genes provides information important for making clinically significant decisions.
Fields of Study & Subjects
Acute Myeloid Leukemia Research
Retinoids in leukemia and cellular processes
Cancer Genomics and Diagnostics
Publication details
- Journal / source
- JOURNAL of SIBERIAN MEDICAL SCIENCES
- Volume
- 10
- Issue
- 1
- Pages
- 7–20
- Publication date
- 1 January 2026
- Language
- EN